Professional heparin API manufacturer with vertical industry integration

Global supplier of chondroitin sulfate (pharmaceutical grade and dietary supplement grade)

For over 20 years, Dongcheng has been deeply involved in the development of raw material medicine business and has become a vertically integrated professional heparin API manufacturer, global supplier of pharmaceutical grade and dietary supplement grade chondroitin sulfate, and one of the domestic biochemical raw material medicine production bases.

The heparin industry has rich production experience and strong production capacity. Dongcheng Pharmaceutical continuously strengthens the improvement of the heparin industry chain and has a vertically integrated industrial structure, ensuring product quality and traceability.

The company has an excellent background in qualification certification: domestic heparin sodium suppliers have passed the MFDS GMP audit of the South Korean Food and Drug Administration, passed the on-site inspection of PMDA GMP in Japan, and have GMP certificates issued by BGV in Hamburg, Germany and CFDA in China, as well as CEP certificates issued by EDQM in Europe; At the same time, the company assisted in the revision of standards for heparin sodium raw materials in the Chinese Pharmacopoeia (2010/2015 edition), European Pharmacopoeia, and United States Pharmacopoeia; The company participated in the heparin sodium expert group meeting held at USP headquarters in the United States as a supplier of heparin sodium raw materials.

As a domestic producer of chondroitin sulfate, the company currently has strong capabilities in research and development, quality, and sales. In 2016, the company acquired Zhongtai Biological Products Co., Ltd., further consolidating its position in the global chondroitin industry. In terms of qualification certification, the company is a chondroitin chondroitin producer certified by USP-DSIVP in the United States in China; Obtained CEP certificate issued by the EU EDQM, GMP certificate issued by BGV in Hamburg, Germany, MFDS in South Korea, ANVISA in Brazil, and CFDA in China. Given the company's technical authority in the domestic biochemical industry, it was invited to participate in the formulation of the quality standards for chondroitin sulfate sodium products in the Chinese Pharmacopoeia (2010/2015 edition).

The company has a well-established global sales network, with over 90% of its active pharmaceutical ingredients exported and sold in more than 40 countries and regions worldwide. Its partnerships with top pharmaceutical companies continue to grow steadily, and it has established close cooperation with internationally renowned dietary supplement manufacturers; And establish good cooperative relationships with well-known domestic pharmaceutical companies.